Cgp 52608
| Code | Size | Price |
|---|
| TAR-T30838-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
CGP 52608 is a selective ligand for RAR-associated orphan receptor alpha.
CAS:
87958-67-6
Formula:
C8H12N4OS2
Molecular Weight:
244.33
Purity:
0.98
SMILES:
CNC(=S)NN=C1SCC(=O)N1CC=C
References
1. Winczyk K, Lawnicka H, Pawlikowski M, Kunert-Radek J, Karasek M. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells. Neuro Endocrinol Lett. 2006 Jun;27(3):351-4. PubMed PMID: 16816834.
2. Herrera F, Mayo JC, Mart?n V, Sainz RM, Antolin I, Rodriguez C. Cytotoxicity and oncostatic activity of the thiazolidinedione derivative CGP 52608 on central nervous system cancer cells. Cancer Lett. 2004 Jul 28;211(1):47-55. PubMed PMID: 15194216.
3. Winczyk K, Pawlikowski M, Karasek M. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J Pineal Res. 2001 Sep;31(2):179-82. PubMed PMID: 11555175.
4. Karasek M, Pawlikowski M. Antiproliferative effects of melatonin and CGP 52608. Biol Signals Recept. 1999 Jan-Apr;8(1-2):75-8. PubMed PMID: 10085466.